Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.

Multiple sclerosis (Houndmills, Basingstoke, England)（2023）

引用 0|浏览6

暂无评分

摘要

ALITHIOS (NCT03650114): https://clinicaltrials.gov/ct2/show/NCT03650114.

查看译文

关键词

Relapsing-remitting multiple sclerosis, ofatumumab, monoclonal antibodies, treatment, follow-up

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要